{
    "2020-12-13": [
        [
            {
                "time": "",
                "original_text": "私募争鸣系列｜森瑞投资林存：为什么医药投资里，我们一直推荐CXO产业",
                "features": {
                    "keywords": [
                        "私募",
                        "医药投资",
                        "CXO产业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}